Stocks and Investing
Stocks and Investing
Thu, February 29, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Wed, February 28, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Edward White Reiterated (SNDX) at Strong Buy and Held Target at $41 on, Feb 28th, 2024
Edward White of HC Wainwright & Co., Reiterated "Syndax Pharmaceuticals, Inc." (SNDX) at Strong Buy and Held Target at $41 on, Feb 28th, 2024.
Edward has made no other calls on SNDX in the last 4 months.
There are 2 other peers that have a rating on SNDX. Out of the 2 peers that are also analyzing SNDX, 1 agrees with Edward's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- George Farmer of "Scotiabank" Downgraded from Buy to Hold and Decreased Target to $23 on, Wednesday, January 31st, 2024
This is the rating of the analyst that currently disagrees with Edward
- Mara Goldstein of "Mizuho" Initiated at Strong Buy and Held Target at $45 on, Friday, December 22nd, 2023
Contributing Sources